Acute angle-closure glaucoma complicating an intravitreal injection of bevacizumab;Glaucome aigu par fermeture de l'angle compliquant une injection intravitréenne de bevacizumab

Journal Francais d'Ophtalmologie

Volumn 32, Issue 1, 2009, Pages

  Semoun, O ^a   Blumen Ohana, E ^a   de Preobrajensky, N ^a   Nordmann, J P ^a  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

Acute angle closure glaucoma; Bevacizumab; Intravitreal injection

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

ACUTE DISEASE; AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CLOSED ANGLE GLAUCOMA; FEMALE; HUMAN; INJECTION; VITREOUS BODY;

ACUTE DISEASE; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; GLAUCOMA, ANGLE-CLOSURE; HUMANS; INJECTIONS; VITREOUS BODY;

EID: 60349113551     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2008.11.002     Document Type: Article

References (8)

1. Fajnkuchen F., and Cohen S.Y. Age-related macular degeneration and antivascular endothelial growth factor : a review. J Fr Ophtalmol 31 (2008) 94-110
2. Iliev M.E., Domig D., Wolf-Schnurrbursch U., Wolf S., and Sarra G.M. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 142 (2006) 1054-1056
3. Ferrara N., Damico L., Shams N., Lowman H., and Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26 (2006) 859-870
4. Hollands H., Wong J., Bruen R., Campbell R.J., Sharma S., and Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 42 (2007) 807-811
5. Cohen S.Y., Korobelnik J.F., Tadayoni R., Coscas G., Creuzot-Garcher C., Devin F., Gaudric A., Mauget-Faysse M., Sahel J.A., Souied E., Weber M., and Soubrane G. Monitoring anti-VEGF drugs for treatment of exudative AMD. J Fr Ophtalmol 30 (2007) 330-334
6. Lynch S.S., and Cheng C.M. Bevacizumab for neovascular ocular diseases. Ann Pharmacother 41 (2007) 614-625
7. Bakri S.J., Pulido J.S., McCannel C.A., Hodge D.O., Diehl N., and Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (2007, Aug 10) [Epub ahead of print]
8. Jalil A., Fenerty C., and Charles S. Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication. Eye 21 (2007) 1541